Inflammatory bowel disease (IBD) is a group of chronic conditions in which the immune system attacks the lining of the digestive tract, causing ongoing inflammation, pain, and damage. Between 2.4 and 3.1 million Americans currently live with IBD, which includes two main conditions: Crohn’s disease and ulcerative colitis. Though they share many symptoms, these two diseases behave differently in the body and require distinct approaches to treatment.
Crohn’s Disease vs. Ulcerative Colitis
The two forms of IBD are distinguished primarily by where they strike and how deep the inflammation goes.
Ulcerative colitis is confined to the large intestine (colon). It typically starts in the rectum and spreads upward in a continuous line with no gaps between inflamed areas. The inflammation stays shallow, limited to the innermost lining of the colon wall.
Crohn’s disease can affect any part of the digestive tract, from the mouth to the anus, though it most commonly targets the end of the small intestine and the beginning of the colon. Unlike ulcerative colitis, Crohn’s often skips areas, leaving patches of healthy tissue between inflamed spots. It also penetrates deeper, potentially involving all layers of the intestinal wall. This deeper inflammation is what makes Crohn’s more likely to cause complications like narrowing of the intestine (strictures) or tunnels between organs (fistulas).
What Causes the Inflammation
IBD is not caused by something you ate or a single infection. It develops when immune cells in the gut become hyperactivated and begin releasing excessive inflammatory signaling molecules. In a healthy gut, the immune system fights off threats and then calms down. In IBD, that “off switch” is broken.
Specialized immune cells that normally reside in the intestinal lining persist there for long periods and are rapidly reactivated, even after a flare subsides. These cells pump out inflammatory signals that recruit still more immune cells to the area, creating a self-reinforcing cycle of damage. Over time, the balance between pro-inflammatory cells and the regulatory cells that would normally keep them in check shifts heavily toward inflammation. The result is chronic tissue injury that can worsen with each flare.
The exact trigger for this immune malfunction isn’t fully understood, but it involves a combination of genetic susceptibility, environmental factors, and changes in gut bacteria. Having a first-degree relative with IBD significantly raises your risk, though many people with IBD have no family history at all.
Common Symptoms
Both forms of IBD share a core set of gut symptoms: persistent diarrhea (often bloody in ulcerative colitis), abdominal cramping, urgency to use the bathroom, fatigue, and unintended weight loss. Symptoms tend to come and go in cycles of flares and remission, and the severity varies widely from person to person.
IBD is not just a digestive disease. It can cause problems well beyond the gut, including joint pain and arthritis, skin lesions, and eye inflammation (uveitis). These extraintestinal symptoms often flare alongside intestinal symptoms, though they can sometimes appear independently. Fatigue is one of the most common complaints and can persist even during remission.
How IBD Is Diagnosed
There is no single test that confirms IBD. Diagnosis relies on combining clinical symptoms, blood work, stool tests, imaging, and direct visualization of the intestine. The cornerstone procedure is a colonoscopy with biopsies, during which a gastroenterologist examines the colon and the end of the small intestine and takes small tissue samples from both inflamed and healthy-looking areas.
Under a microscope, the biopsy patterns help distinguish between the two conditions. Crohn’s disease often shows granulomas (small clusters of immune cells) and patchy inflammation, while ulcerative colitis typically shows a specific pattern of immune cell buildup at the base of the intestinal glands. These patterns also help rule out infections, which look different on biopsy because they tend to leave the overall architecture of the intestinal lining intact.
A stool test measuring a protein called calprotectin is often used early in the workup. High calprotectin levels indicate intestinal inflammation and point toward IBD rather than a non-inflammatory condition like irritable bowel syndrome, which can cause similar day-to-day symptoms. This same test is useful later for monitoring flares without needing repeated colonoscopies.
Treatment Approaches
The goal of IBD treatment is to reduce inflammation enough that the intestinal lining can heal, then keep it healed for as long as possible. Treatment is tailored to the type and severity of IBD, and most people cycle through several options over their lifetime.
For mild to moderate disease, anti-inflammatory medications are often the first step. When those aren’t enough, immune-modifying drugs that broadly dial down the immune response may be added. For moderate to severe disease, biologic therapies have become a mainstay. These are targeted medications delivered by injection or infusion, and they work in three main ways:
- TNF blockers attach to a specific inflammatory protein (TNF) and prevent it from delivering its inflammatory message to other cells.
- Integrin blockers reduce the number of inflammatory white blood cells that can migrate into the gut lining, giving it a chance to heal.
- Interleukin blockers intercept signaling molecules (IL-12 and IL-23) that amplify the immune response. Newer versions target only IL-23, aiming to be more precise with fewer side effects.
Finding the right medication often involves trial and adjustment. What works well for one person may not work for another, and effectiveness can diminish over time, requiring a switch to a different class.
When Surgery Becomes Necessary
Surgery is not a first-line treatment, but it becomes necessary for a significant number of people. Among those diagnosed with Crohn’s disease, roughly 8% need surgery within the first year, 14% within five years, and nearly 19% within ten years. The most common procedures involve removing the affected section of intestine, particularly at the junction of the small and large intestine.
For ulcerative colitis, removing the entire colon is curative since the disease is confined there. Surgeons can often construct an internal pouch from the end of the small intestine and connect it to the rectum, preserving the ability to have bowel movements without a permanent external bag. Crohn’s disease, because it can recur anywhere in the digestive tract, is not cured by surgery, but operations to remove damaged sections or drain abscesses can provide significant relief.
Long-Term Cancer Risk
People with IBD that involves the colon have an elevated risk of colorectal cancer, with a lifetime incidence of about 5%. The risk is driven by years of chronic inflammation damaging the cells that line the colon. Screening colonoscopies should begin 8 to 10 years after symptoms first appeared, with repeat surveillance every one to three years afterward. Keeping inflammation well controlled is one of the most effective ways to reduce this risk over time.
Diet and Nutrition
No specific diet has been consistently shown to prevent IBD flares in adults. That said, the American Gastroenterological Association recommends that people with IBD follow a Mediterranean-style diet: rich in fresh fruits and vegetables, healthy fats like olive oil, complex carbohydrates, and lean proteins, while limiting ultraprocessed foods, added sugar, and excess salt. This approach supports overall health and may help manage low-grade inflammation.
During flares, the practical challenge is tolerating high-fiber foods, especially for people with intestinal strictures. Cooking vegetables until soft, blending fruits into smoothies, and chewing thoroughly can make plant-based foods more manageable without eliminating them entirely. Nutritional deficiencies in iron, vitamin B12, vitamin D, and zinc are common in IBD, particularly in Crohn’s disease affecting the small intestine where these nutrients are absorbed. Regular monitoring and supplementation when needed are a routine part of long-term care.